Clinical practice. The care of children with Down syndrome

Michel E Weijerman, J Peter de Winter, Michel E Weijerman, J Peter de Winter

Abstract

Down syndrome (DS) is one of the most common chromosomal abnormalities. Because of medical advances and improvements in overall medical care, the median survival of individuals with DS has increased considerably. This longer life expectancy requires giving the necessary care to the individual with DS over their total longer lifespan. DS medical guidelines are designed for the optimal care of the child in whom a diagnosis of DS has been confirmed. We present an overview of the most important issues related to children with DS based on the most relevant literature currently available.

Figures

Fig 1
Fig 1
A 4-year-old boy with Down syndrome
Fig 2
Fig 2
A 2-year-old girl with Down syndrome
Fig. 3
Fig. 3
Transverse line in the palm of the hand (“Simian fold”)
Fig. 4
Fig. 4
Brushfield spots
Fig 5
Fig 5
Valgus posture of the ankle and pes planus, a typical example of joint laxity

References

    1. Bertrand P, Navarro H, Caussade S, et al. Airway anomalies in children with Down syndrome: endoscopic findings. Ped Pulm. 2003;36:137–141. doi: 10.1002/ppul.10332.
    1. Biko DM, Schwartz M, Anupindi SA, Altes TA. Subpleural lung cysts in Down syndrome: prevalence and association with coexisting diagnoses. Pediatr Radiol. 2008;38:280–284. doi: 10.1007/s00247-007-0699-3.
    1. Bloemers BLP, van Furth AM, Weijerman ME, et al. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis—a prospective birth-cohort study. Pediatrics. 2007;120:e1076–e1081. doi: 10.1542/peds.2007-0788.
    1. Bloemers BLP, van Furth AM, Weijerman ME, et al. High incidence of recurrent wheeze in children with Down syndrome with and without previous respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J. 2010;29:39–42. doi: 10.1097/INF.0b013e3181b34e52.
    1. Caird MS, Wills BP, Dormans JP. Down syndrome in children: the role of the orthopaedic surgeon. J Am Acad Orthop Surg. 2006;14:610–619.
    1. Collins VR, Muggli EE, Riley M, et al. Is Down syndrome a disappearing birth defect? J Pediatr. 2008;152:20–24. doi: 10.1016/j.jpeds.2007.07.045.
    1. Cremers MJ, van der Twee I, Boersma B, et al. Growth curves of Dutch children with Down syndrome. J Intellect Disabil Res. 1996;40:412–420. doi: 10.1111/j.1365-2788.1996.tb00648.x.
    1. Cunnif C, Frias JL, Kaye C, et al. Health supervision for children with Down syndrome, American Academy of Pediatrics. Pediatrics. 2001;107:442–449. doi: 10.1542/peds.107.2.442.
    1. Freeman SB, Torfs CA, Romitti MH, et al. Congenital gastrointestinal defects in Down syndrome: a report from the Atlanta and National Down Syndrome Projects. Clin Genet. 2009;75:180–184. doi: 10.1111/j.1399-0004.2008.01110.x.
    1. Gibson PA, Newton RW, Selby K, et al. Longitudinal study of thyroid function in Down’s syndrome in the first two decades. Arch Dis Child. 2005;09:575–578.
    1. Guidelines for basic essential medical surveillance. The Down’s syndrome medical interest group UK and Ireland. Available at: Accessed 29 Jan 2010
    1. Hankinson TC, Anderson RC. Craniovertebral junction abnormalities in Down syndrome. Neurosurgery. 2010;66:A32–A38. doi: 10.1227/01.NEU.0000365803.22786.F0.
    1. Hilton JM, Fitzgerald DA, Cooper DM. Respiratory morbidity of hospitalized children with Trisomy 21. Paediatr Child Health. 1999;35:383–386. doi: 10.1046/j.1440-1754.1999.00386.x.
    1. Irving C, Basu A, Richmond S, et al. Twenty-year trends in prevalence and survival of Down syndrome. Eur J Hum Genet. 2008;16:1336–1340. doi: 10.1038/ejhg.2008.122.
    1. Kishnani PS, Crissman BG. Special issue: current perspectives on Down syndrome: selected medical and social issues. Am J Med Genet C Semin Med Genet. 2006;142C:127–205. doi: 10.1002/ajmg.c.30099.
    1. Kupferman JC, Druschel CM, Kupchik GS. Increased prevalence of renal urinary tract anomalies in children with Down syndrome. Pediatrics. 2009;124:e615–e621. doi: 10.1542/peds.2009-0181.
    1. Mannan SE, Ejaz Y, Hossain J. Prevalence of positive skin prick test results in children with Down syndrome: a case control study. Ann Allergy Asthma Immunol. 2009;102:2005–2009. doi: 10.1016/S1081-1206(10)60082-8.
    1. Madan V, Williams J, Lear JT. Dermatological manifestations of Down’s syndrome. Clin Exp Dermatol. 2006;31(5):623–629. doi: 10.1111/j.1365-2230.2006.02164.x.
    1. Muggli EE, Collins VR, Marraffa C. Going down a different road: first support and information needs of families with a baby with Down syndrome. MJA. 2009;190:58–61.
    1. Rex AP, Preus M. A diagnostic index for Down syndrome. J Pediatr. 1982;6:903–906.
    1. Roizen NJ, Patterson D. Down’s syndrome. Lancet. 2003;361:1281–1289. doi: 10.1016/S0140-6736(03)12987-X.
    1. Roofthooft MT, van Meer H, Rietman WG, et al. Down syndrome and aberrant right subclavian artery. Eur J Pediatr. 2008;167:1033–1036. doi: 10.1007/s00431-007-0637-2.
    1. Schepis C, Barone C, Siragusa M, et al. An updated survey on skin conditions in Down syndrome. Dermatology. 2002;20:234–238. doi: 10.1159/000065859.
    1. Shin M, Besser LM, Kucik JE, et al. Prevalence of Down Syndrome among children and adolescents in 10 regions of the United States. Pediatrics. 2009;124:1565–1571. doi: 10.1542/peds.2009-0745.
    1. Shott SR, Amin R, Chini B, et al. Obstructive sleep apnea should all children with Down syndrome be tested? Arch Otolaryngol Head Neck Surg. 2006;132:432–436. doi: 10.1001/archotol.132.4.432.
    1. Skotko BG, Capone GT, Kishnani S. Postnatal diagnosis of Down syndrome: synthesis of the evidence on how best to deliver the news. Pediatrics. 2009;124:e751–e758. doi: 10.1542/peds.2009-0480.
    1. Stephen E, Dickson J, Kindley AD, et al. Surveillance of vision and ocular disorders in children with Down syndrome. Dev Med Child Neurol. 2007;49:513–515. doi: 10.1111/j.1469-8749.2007.00513.x.
    1. Unachak K, Tanpaiboon P, Yupada Pongprot Y, et al. Thyroid functions in children with Down’s syndrome. J Med Assoc Thai. 2008;91:56–61.
    1. van Trotsenburg ASP, Vulsma T, van Rozenburg-Marres SLR, et al. The Effect of thyroxine treatment started in the neonatal period on developmentand growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab. 2005;90:3304–3311. doi: 10.1210/jc.2005-0130.
    1. van Wouwe JP, Siderius EJ, Borstlap R, et al. Optimal medical care for children with Down syndrome and their parents. Ned Tijdschr Geneeskd. 2001;145:1617–1621.
    1. Vis JC, Duffels MGJ, Winter MM, et al. Down syndrome: a cardiovascular perspective. J Intellect Disabil Res. 2009;53:419–425. doi: 10.1111/j.1365-2788.2009.01158.x.
    1. Volman MJ, Visser JJ, Lensvelt-Mulders GJ. Functional status in 5 to 7-year-old children with Down syndrome in relation to motor ability and performance mental ability. Disabil Rehabil. 2007;29:25–31. doi: 10.1080/09638280600947617.
    1. Weijerman ME, van Furth AM, Vonk Noordegraaf A, et al. Prevalence, neonatal characteristics and first-year mortality of Down syndrome: a national study. J Pediatrics. 2008;152:15–19. doi: 10.1016/j.jpeds.2007.09.045.
    1. Weijerman ME, van Furth AM, Mooren MD, et al. Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr. 2010
    1. Wiseman FK, Alford KA, Tybulewicz VL, et al. Down syndrome—recent progress and future prospects. Hum Mol Genet. 2009;18(R1):75–83. doi: 10.1093/hmg/ddp010.
    1. Wong V, Ho D. Ocular abnormalities in Down syndrome: an analysis of 140 Chinese children. Pediatr Neurol. 1997;16:311–314. doi: 10.1016/S0887-8994(97)00029-5.
    1. Wouters J, Weijerman ME, van Furth AM, et al. Prospective HLA, EMA, and TGA testing celiac disease in children with Down syndrome. J Pediatrics. 2009;154:239–242. doi: 10.1016/j.jpeds.2008.08.007.
    1. Yang Q, Rasmussen SA, Friedma JM. Mortality associated with Down’s syndrome in the USA from 1983 to 1997: a population-based study. Lancet. 2002;359:1019–1025. doi: 10.1016/S0140-6736(02)08092-3.
    1. Zwaan MC, Reinhardt DR, Hizler J, Vyas P. Acute leukemias in children with Down syndrome. Pediatr Clin North Am. 2008;55:53–70. doi: 10.1016/j.pcl.2007.11.001.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever